122 related articles for article (PubMed ID: 2331676)
21. Role of chromosome 9 in human bladder cancer.
Miyao N; Tsai YC; Lerner SP; Olumi AF; Spruck CH; Gonzalez-Zulueta M; Nichols PW; Skinner DG; Jones PA
Cancer Res; 1993 Sep; 53(17):4066-70. PubMed ID: 8358736
[TBL] [Abstract][Full Text] [Related]
22. [Low-grade and low-stage transitional carcinoma of the bladder. Review].
Escudero Barrilero A; Gutiérrez Sanz Gadea C; Hernández Fernández C; Romero Maroto J; Tallada Buñuel M; Perales Cabanas L
Actas Urol Esp; 1985; 9(3):203-8. PubMed ID: 3898736
[No Abstract] [Full Text] [Related]
23. Detection of chromosomal imbalances in papillary bladder tumors by comparative genomic hybridization.
Prat E; Bernués M; Caballín MR; Egozcue J; Gelabert A; Miró R
Urology; 2001 May; 57(5):986-92. PubMed ID: 11337313
[TBL] [Abstract][Full Text] [Related]
24. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F
Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
[TBL] [Abstract][Full Text] [Related]
25. Characterization of a new human bladder cancer cell line, UCRU-BL-28.
Russell PJ; Palavidis Z; Rozinova E; Philips J; Wills EJ; Lukeis R; Wass J; Raghavan D
J Urol; 1993 Sep; 150(3):1038-44. PubMed ID: 8345582
[TBL] [Abstract][Full Text] [Related]
26. Characterization of chromosomal abnormalities in uroepithelial carcinomas by G-banding, spectral karyotyping and FISH analysis.
Fadl-Elmula I; Kytölä S; Pan Y; Lui WO; Derienzo G; Forsberg L; Mandahl N; Gorunova L; Bergerheim US; Heim S; Larsson C
Int J Cancer; 2001 Jun; 92(6):824-31. PubMed ID: 11351302
[TBL] [Abstract][Full Text] [Related]
27. A possible specific chromosome change in transitional cell carcinoma of the bladder.
Gibas Z; Prout GR; Pontes JE; Connolly JG; Sandberg AA
Cancer Genet Cytogenet; 1986 Jan; 19(3-4):229-38. PubMed ID: 3943046
[TBL] [Abstract][Full Text] [Related]
28. Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder.
Cappellen D; Gil Diez de Medina S; Chopin D; Thiery JP; Radvanyi F
Oncogene; 1997 Jun; 14(25):3059-66. PubMed ID: 9223669
[TBL] [Abstract][Full Text] [Related]
29. Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder.
Kimura F; Florl AR; Seifert HH; Louhelainen J; Maas S; Knowles MA; Schulz WA
Br J Cancer; 2001 Dec; 85(12):1887-93. PubMed ID: 11747331
[TBL] [Abstract][Full Text] [Related]
30. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].
Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR
Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751
[TBL] [Abstract][Full Text] [Related]
31. Serial cytogenetic analysis in a patient with pseudodiploid bladder cancer.
Kovacs G
J Cancer Res Clin Oncol; 1985; 110(3):249-51. PubMed ID: 4077924
[TBL] [Abstract][Full Text] [Related]
32. Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder.
Keen AJ; Knowles MA
Oncogene; 1994 Jul; 9(7):2083-8. PubMed ID: 8208555
[TBL] [Abstract][Full Text] [Related]
33. Fifty-three month persistence of ring chromosome in noninvasive bladder carcinoma.
Falor WH; Ward RM
Acta Cytol; 1976; 20(3):272-5. PubMed ID: 1064279
[TBL] [Abstract][Full Text] [Related]
34. High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder.
Gonzalez-Zulueta M; Shibata A; Ohneseit PF; Spruck CH; Busch C; Shamaa M; El-Baz M; Nichols PW; Gonzalgo ML; Elbaz M [corrected to El-Baz M]
J Natl Cancer Inst; 1995 Sep; 87(18):1383-93. PubMed ID: 7658499
[TBL] [Abstract][Full Text] [Related]
35. Assessment by M-FISH of karyotypic complexity and cytogenetic evolution in bladder cancer in vitro.
Ratliff TL
J Urol; 2005 Nov; 174(5):2065. PubMed ID: 16217396
[No Abstract] [Full Text] [Related]
36. Two molecular pathways to transitional cell carcinoma of the bladder.
Spruck CH; Ohneseit PF; Gonzalez-Zulueta M; Esrig D; Miyao N; Tsai YC; Lerner SP; Schmütte C; Yang AS; Cote R
Cancer Res; 1994 Feb; 54(3):784-8. PubMed ID: 8306342
[TBL] [Abstract][Full Text] [Related]
37. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
[TBL] [Abstract][Full Text] [Related]
38. A routine method for cytogenetic analysis of small urinary bladder tumor biopsies.
Fraser C; Sullivan LD; Kalousek DK
Cancer Genet Cytogenet; 1987 Nov; 29(1):103-8. PubMed ID: 3664443
[TBL] [Abstract][Full Text] [Related]
39. UM-UC-1 and UM-UC-2: characterization of two new human transitional cell carcinoma lines.
Grossman HB; Wedemeyer G; Ren L
J Urol; 1984 Oct; 132(4):834-7. PubMed ID: 6471236
[TBL] [Abstract][Full Text] [Related]
40. The role of different biomarkers (DNA, PCNA, apoptosis and karyotype) in prognostic evaluation of superficial transitional cell bladder carcinoma.
Lavezzi AM; Biondo B; Cazzullo A; Giordano F; Pallotti F; Turconi P; Matturri L
Anticancer Res; 2001; 21(2B):1279-84. PubMed ID: 11396199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]